TB-Related Articles
Journal Articles Published by Division of TB Elimination (DTBE) Authors
2011 DTBE journal articles
Adekambi T, Butler WR, Hanrahan F, Delcher AL, Drancourt M, and Shinnick TM. Core gene set as the basis of multilocus sequence analysis of the subclass Actinobacteridae. PLoS One 2011 Mar 31; 6(3): e14792. Epub date April 13, 2011.
Barnes RFW, Moore ML, Garfein RS, Brodine S, Strathdee SA, and Rodwell TC. Trends in mortality of tuberculosis patients in the United States: the long-term perspective. Annals of Epidemiology 2011 Oct; 21 (10): 791–795.
Blaya JA, Shin S, Contreras C, Yale G, Suarez C, Asencios L, Kim J, Rodriguez P, Cegielski P, Fraser HSF. Full impact of laboratory information system requires direct use by clinical staff: cluster randomized controlled trial. Journal of the American Medical Informatics Association 2011 Jan; 18(1):11–16.
Bloss E, Holtz TH, Jereb J, Redd JT, Podewils LJ, Cheek JE, McCray E. Tuberculosis in indigenous peoples. Public Hlth Reports 2011 Sept–Oct; 126: 677–689.
Bloss E, Newbill K, Peto H, Rice MJ, Ainsworth G, Travnicek R, Holcombe M, Haddad MB, and Oeltmann JE. Challenges and opportunities in a tuberculosis outbreak investigation in southern Mississippi, 2005 – 2007. Southern Med J. 2011 Nov; 104(11): 731–5.
Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens, Cox FH, Alland D and Perkins MD. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377(9776): 1495–1505.
Brostrom R, Fred D, Heetderks A, Desai M, Song R, Haddad M, Wada R, Bamrah S. Islands of hope: building local capacity to manage an outbreak of multidrug-resistant tuberculosis in the Pacific. American Journal of Public Health 2011 Jan; 101(1):14–18.
Cain KP and Varma JK. You have to find TB to treat TB. [Editorial.] Int J Tuberc Lung Dis 2011 July; 15(7): 854.
Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. Molecular detection of mutations associated with first– and second-line drug resistance compared with conventional drug susceptibility testing in M. tuberculosis. Antimicrob Agents Chemother 2011 May; 55(5): 2032–2041. Epub date Feb 7.
Castro KG, Cohn DL, Burman WJ, Reves RR, Iseman MD. John A. Sbarbaro, 1936–2011. [Obituary.] IJTLD 2011 Nov; 15 (11): 1562.
Castro KG, LoBue P. Bridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globally. Emerg Infect Dis Mar 2011. Available at http://www.cdc.gov/EID/content/17/3/337.htm
Cavanaugh J, Genga K, Marigu I, Laserson K, Ackers M, Cain K. Tuberculosis among children in Kenya: epidemiology and impact of HIV in two provinces. J Trop Pediatr 2011 Dec 5. [Epub ahead of print.]
Chaisson LH, Kass NE, Chengeta B, Mathebula U, Samandari T. Repeated assessments of informed consent comprehension among HIV-infected participants of a three-year clinical trial in Botswana. PLoS ONE 2011; 6(10): e22696. doi:10.1371/journal.pone.0022696.
Davidson CS, Green CF, Gibbs SG, Panlilio AL, Jensen PA, Jin Y, Scarpino PV. Feasibility of selected prophylactic barriers in arrestance of airborne bacterial vegetative cells and endospores. Am J Infect Control 2011; 39: 581–6.
Davidson C, Green CF, Panlilio AL, Jensen PA, Stover BH, Roselle G, Gibbs SG, and Scarpino PV. Method for evaluating the relative efficiency of selected N95 respirators and surgical masks to prevent the inhalation of airborne vegetative cells by healthcare personnel. Indoor and Built Environment 2011 Apr; 20 (2): 265–277.
Dharmadhikari AS, Basaraba RJ, Van Der Walt ML, Weyer K, Mphahlele M, Venter K, Jensen PA, First MW, Parsons S, McMurray DN, Orme IM, and Nardell EA. Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis. Tuberculosis 2011 Jul; 91 (4): 329–338.
Factor SH, Sackoff JE, Raj-Singh S, Wu Y, Monserrate J, Munsiff S, and Vlahov D. Street-outreach improves detection but not referral for drug users with latent tuberculosis, New York City. Journal: Substance Use & Misuse 2011; 46 (14): 1711–1715.
Falzon D, Jaramillo E, Schünemann HJ, Arentz M, Bauer M, Bayona J, Blanc L, Caminero JA, Daley CL, Duncombe C, Fitzpatrick C, Gebhard A, Getahun H, Henkens M, Holtz TH, Keravec J, Keshavjee S, Khan AJ, Kulier R, Leimane V, Lienhardt C, Lu C, Mariandyshev A, Migliori GB, Mirzayev F, Mitnick CD, Nunn P, Nwagboniwe G, Oxlade O, Palmero D, Pavlinac P, Quelapio MI, Raviglione MC, Rich ML, Royce S, Rüsch-Gerdes S, Salakaia A, Sarin R, Sculier D, Varaine F, Vitoria M, Walson JL, Wares F, Weyer K, White RA, and Zignol M. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38:516–528.
Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MID, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski JP. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects. Int J Tuberc Lung Dis 2011; 15(10):1315–1322.
Getahun H, Kittikraisak W, Heilig CM, Corbett E, Ayles H, Cain KP, Grant AD, Churchyard G, Kimerling M, Shah S, Lawn SD, Wood R, Maartens G, Granich R, Date A, Varma JK. Development of a standardized screening rule for tuberculosis in people living with HIV in resource constrained settings: individual participant data meta-analysis of observational studies. PLoS Medicine 2011; 8: e1000391.
Ghosh S, Moonan PK, Cowan L, Grant J, Kammerer S, Navin T. Tuberculosis Genotyping Information Management System: Enhancing tuberculosis surveillance in the United States. Infection, Genetics, and Evolution 2011; doi: 10.1016/ j.meegid.2011.10.013.
Goodchild M, Sahu S, Wares F, Dewan P, Shukla RS, Chauhan LS, Floyd K. A cost-benefit analysis of scaling up tuberculosis control in India. Int J Tuberc Lung Dis 2011 Mar; 15(3): 358–62.
Grinsdale JA, Ho CS, Banouvong H, Kawamura LM. Programmatic impact of using QuantiFERON®–TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis 2011 Dec; 15(12):1614–1619.
Guh A, Sosa L, Hadler JL, Lobato MN. Missed opportunities to prevent tuberculosis in foreign-born persons, Connecticut, 2005–2008. Int J Tuberc Lung Dis 2011 Aug; 15(8): 1044–9.
Gust DA, Mosimaneotsile B, Mathebula U, Chingapane B, Gaul Z, Pals SL and Samandari T. Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana. PLoS One 2011; 6 (4): e18435.
He GX, Wang HY, Borgdorff MW, van Soolingen D, van der Werf MJ, Liu ZM, Li XZ, Guo H, Zhao YL, Varma JK, Tostado CP, van den Hof S. Multidrug-resistant tuberculosis, People’s Republic of China, 2007–2009. Emerg Infect Dis [serial on the Internet]. 2011 Oct.
Heilig CM, Chia D, El-Sadr WM, Hirsch-Moverman Y, Mac Kenzie WR, Saukkonen S, Villarino ME, and Padayatchi N. Justifying research risks in a clinical trial for treatment of multidrug-resistant tuberculosis. IRB: Ethics & Human Research 2011 July–August; 33 (4): 10–17.
Hiraishi Y, Nandakumar S, Choi S.–O, Lee JW, Kim Y–C, Posey JE, Sable SB, Prausnitz MR. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine 2011 Mar 21; 29 (14): 2626–2636.
Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, Ross D, Allen J, Chideya S, Sunpath H, Rustomjee R. Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis 2011; 11(7): 533–40.
Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, Zajdowicz MJ, Scarborough R, LoBue PA, Lardizabal AA, Daley CL8, Reves RR, Bernardo J, Campbell BH, Whitworth WC, Mazurek GH. Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 2011; 6(11): e26545. doi:10.1371/journal.pone.0026545
Kurbatova EV, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MID, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment. [Short communication.] Int J Tuberc Lung Dis 2011; 15(11):1553–1555.
Kvasnovsky CL, Cegielski JP, Erasmus R, Siwisa NO, Thomas K, Van Der Walt ML. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV negative and HIV positive patients. J Acquir Immune Defic Syndr. 2011 Jun 1; 57(2): 146–52. Epub date Feb 4.
Lee LM, Heilig CM, White A. Ethical justification for conducting public health surveillance without patient consent. Am J Public Health 2011 Nov 17; e1–e7. Published online ahead of print; doi: 10.2105/AJPH.2011.300297.
Lin H, Shin S, Blaya JA, Zhang Z, Cegielski P, Contreras C, Asencios L, Bonilla C, Bayona J, Paciorek CJ, and Cohen T. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology and Infection 2011 Nov; 139 (11): 1784–1793.
Livingston KA, Lobato MN, Sosa LE, Budnick GE, Bernardo L, and the New England Laboratory Study Group. Mycobacterium tuberculosis testing practices in hospital, commercial and state laboratories in the New England states. IJTLD 2011 Sept; 15(9): 1218–1222.
LoBue P. Cohort study: People aged above 65 treated for latent tuberculosis are at increased risk of admission for a hepatic event compared with untreated controls. [Commentary.] Evid Based Med 2011 June 6. Epub date June 8, 2011.
Lowenthal P, Westenhouse J, Moore M, Posey DL, Watt JP, Flood J. Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis 2011 June; 15(6): 761–766.
Lowther SA, Miramontes R, Navara B, Sabuwala N, Brueshaber M, Solarz S, Haddad MB, Sodt D, Lynfield R. Outbreak of tuberculosis among Guatemalan immigrants in rural Minnesota, 2008. Public Health Rep 2011 Sept-Oct; 126:726-732.
Mac Kenzie WR, Heilig CM, Bozeman L, Johnson JL, Muzanye G, Dunbar D, Jost Jr, KC, Diem L, Metchock B, Eisenach K, Dorman S and Goldberg S. Geographic differences in time to culture conversion in liquid media: Tuberculosis Trials Consortium Study 28. Culture conversion is delayed in Africa. PLoS One 2011; 6 (4): e18358.
Macintyre K and Bloss E. Alcohol brewing and the African tuberculosis epidemic. Med Anthropol 2011 Mar; 30 (2): 126–35.
Magee E, Tryon C, Forbes A, Heath B, Manangan L. The national tuberculosis surveillance system training program to ensure accuracy of tuberculosis data. J Public Health Manag Pract 2011 Sep–Oct; 17(5): 427-30.
Magee M, Bloss E, Shin S, Contreras C, Huaman HA, Ticona JC, Bayona J, Bonilla JC, Yagui M, Jave O, and Cegielski P. Factors associated with drug-resistant tuberculosis (DRTB) among patients with tuberculosis (TB) and diabetes mellitus (DM) in Peru. American Journal of Epidemiology 2011 Jun 1; 173: S182–S182.
Manangan LP, Salibay CJ, Wallace RW, Kammerer S, Pratt R, McAllister L, Robison V. Tuberculosis among persons born in the Philippines and living in the United States, 2000–2007. American Journal of Public Health January 2011; 101(1): 101–111.
Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW. Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis 2011 Aug; 53(3): 234–44.
Marks SM. Diabetes and tuberculosis, US National Health Interview Survey, 2000–2005. [Short communication.] Int J Tuberc Lung Dis 2011 July; 15(7): 982–984.
Marks SM, Magee E, Robison V. Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus. Int J Tuberc Lung Dis 2011 Apr; 15(4): 465–70.
Mitruka K, Oeltmann JE, Ijaz K, Haddad MB. Tuberculosis outbreak investigations in the United States, 2002–2008. Emerg Infect Dis [serial on the Internet]. 2011 Mar. Available at http://www.cdc.gov/EID/content/17/3/425.htm.
Moonan PK, Quitugua TN, Pogoda JM, Woo G, Drewyer GB, Sahbazian B, Dunbar D, Jost KC Jr, Wallace C, Weis SE. Does directly observed therapy (DOT) reduce drug-resistant tuberculosis? BMC Public Health 2011; 11(1):19.
Nahid P, Saukkonen J, Mac Kenzie W, Johnson JL, Phillips PJ, Andersen J, Bliven E, Belisle J, Boom H, Luetkemeyer A, Campbell T, Eisenach K, Hafner R, Lennox J, Makhene M, Swindells S, Villarino E, Weiner M, Benson C, Burman W. Tuberculosis biomarker and surrogate endpoint research roadmap. Am J Respir Crit Care Med 2011 Jul 14. [Epub ahead of print].
Napier RJ, Rafi W, Cheruvu M, Powell KR, Zaunbrecher MA, Bornmann W, Salgame P, Shinnick TM, Kalman D. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis. Cell Host & Microbe 2011 Nov 17; 10: 475–485.
Oren E, Winston CA, Pratt R, Robison VA, and Narita M. Epidemiology of urban tuberculosis in the United States, 2000–2007. AJPH 2011; July 2011; 101(7): 1256–1263.
Perri BR, Proops D, Moonan PK, Munsiff SS, Kreiswirth BN, Goranson C, Ahuja SD. Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009. Emerg Infect Dis 2011 Mar; 17(3): 372–8.
Pevzner ES, Vandebriel G, Lowrance DW, Gasana M, and Finlay A. Evaluation of the rapid scale-up of collaborative TB/HIV activities in TB facilities in Rwanda, 2005-2009. BMC Public Health 2011 July; 11: 550.
Podewils LJ, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, Kreigere E, Leimane V. Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiology & Infection 2011 January; 139(1): 113–120.
Powell K, Han D, Hung NV, Vu T, Sy DN, Trinh TT, Le TC, Do K, Oeltmann JE, Whitehead S. Prevalence and risk factors for tuberculosis infection among personnel in two hospitals in Viet Nam. Int J Tuberc Lung Dis 2011; 15(12):1643–1648.
Powell RD III, Whitworth WC, Bernardo J, Moonan PK, Mazurek GH. Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. PLoS ONE 2011; 6(6): e20061. doi:10.1371/journal.pone.0020061
Pratt RH, Winston CA, Kammerer JS and Armstrong LR. Tuberculosis in older adults in the United States, 1993-2008. Journal of the American Geriatrics Society 2011 May 1; 59 (5): 851–857.
Ricks PM, Cain KP, Oeltmann JE , Kammerer JS, Moonan PK. Estimating the burden of tuberculosis among foreign-born persons acquired prior to entering the U.S., 2005–2009. PLoS ONE 2011; 6(11): e27405. doi:10.1371/journal.pone.0027405
Sable SB, Cheruvu M, Nandakumar S, Sharma S, Bandyopadhyay K, Kellar KL, Posey JE, Plikaytis BB, Amara RR, and Shinnick TM. Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS ONE 2011; 6(7): e22718; doi:10.1371/ journal.pone.0022718.
Saito H, Iwamoto T, Ohkusu K, Otsuka Y, Akiyama Y, Sato S, Taguchi O, Sueyasu Y, Kawabe Y, Fujimoto H, Ezaki T, and Butler R. Mycobacterium shinjukuense sp. Nov., a slowly growing , non-chromogenic species isolated from human clinical specimens. IJSEM. V61; 1927-1932,2011. DOI 10.1099/ijs.0.025478-0
Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, Motsamai OI, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat H, Kilmarx PH, Castro KG and Wells CD. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377 (9777): 1588–98.
Samandari T, Bishai D, Luteijn M, Mosimaneotsile B, Motsamai O, Postma M and Hubben G. Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. Am J Respir Crit Care Med 2011; 183 (8): 1103–11.
Samandari T, Moeti T, Talbot E, Agizew T, Nyirenda S. Author’s reply. [Correspondence.] The Lancet 2011 Oct 1; 378; 1216.
Sanchez F, Colomes JLL, Villarino E, and Grosset J. New drugs for tuberculosis treatment. Enfermedades Infecciosas Y Microbiologia Clinica 2011; 29: 47–56.
Schwartzman K, Cain KP. Caveat emptor? Control of latent tuberculosis infection in the United States. [Editorial.] Am J Respir Crit Care Med 2011 Sep 1; 184(5): 501–2.
Simmon, Keith E., Barbara A. Brown-Elliott, Perry G. Ridge, Jacob D. Durtschi, Linda B. Mann, E. Susan Slechta, Arnold G. Steigerwalt, Benjamin D. Moser, Anne M. Whitney, June M. Brown, Karl V. Voelkerding, Karin L. McGowan, Anne F. Reilly, Thomas J. Kirn, W. Ray Butler, Paul H. Edelstein, Richard J. Wallace, and Cathy A Petti. Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, northeastern USA. EID. V17, #9, Sep. 2011. ISSN 1080–6059
Škenders G, Holtz TH, Riekstina V, Leimane V. Implementation of the INNO–LiPA Rif.TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia. Int J Tuberc Lung Dis 2011; 15(11):1546–1552.
Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. Global isoniazid resistance patterns in rifampin-resistant and rifampin-susceptible tuberculosis. [Short communication.] Int J Tuberc Lung Dis e-publication ahead of print 2 December 2011; available at http://dx.doi.org/10.5588/ijtld.11.0445.
Sow FB, Nandakumar S, Velu V, Kellar KL, Schlesinger LS, Amara RR, Lafuse WP, Shinnick TM, Sable SB. Mycobacterium tuberculosis components stimulate production of the antimicrobial peptide hepcidin. Tuberculosis 2011 July; 91 (4): 314–321.
Spencer JS, Kim HJ, Wheat WH, Chatterjee D, Balagon MV, Cellona RV, Tan EV, Gelber R, Saunderson P, Duthie MS, Reece ST, Burman W, Belknap R, Mac Kenzie WR, Geluk A, Oskam L, Dockrell HM, Brennan PJ on behalf of the IDEAL Consortium. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clinical and Vaccine Immunology 2011; 18 (2): 260–7.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Dukes Hamilton C, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Jr., Chaisson RE, for the TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med 2011; 365:2155-66.
Thamthitiwat S, Marin N, Baggett HC, Peruski LF, Kiatkulwiwat W, Panumatrasmee V, Varma JK, Nateniyom S, Akarasewi P, Maloney SA. Mycobacterium bovis (bacille Calmette-Guerin) bacteremia in immunocompetent neonates following vaccination. [Short communication.] Vaccine 2011; 29: 1727–1730.
Velasquez GE, Yagui M, Cegielski JP, Asencios L, Bayona J, Bonilla C, Jave HO, Yale G, Susrez C, Atwood S, Contreras CC, Shin SS. Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005–2008. Emerg Infect Dis 2011 Mar; 17(3): 432-440.
Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid-resistant tuberculous meningitis, United States, 1993–2005. Emerg Infect Dis 2011 Mar. Available at http://www.cdc.gov/EID/content/17/3/539.htm.
Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Multidrug resistant tuberculous meningitis in the United States, 1993–2005. J Infect 2011; published online August 2011; doi:10.1016/j.jinf.2011.07.005.
Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R. Predictors of discordant tuberculin skin test and QuantiFERON®–TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 2011 Aug; 15(8): 1056–61.
Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LCO, Chiu Y, Li J, Ahuja S, Driscoll J, Kreiswirth BN. Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RDRio Mycobacterium tuberculosis sublineage. Infection, Genetics, and Evolution 2011; doi: 10.1016/
j.meegid.2011.07.018.
Williams MM, Chen TH, Keane T, Toney N, Toney S, Armbruster CR, Butler WR, Arduino MJ. Point-of-use membrane filtration and hyperchlorination to prevent patient exposure to rapidly growing mycobacteria in the potable water supply of a skilled nursing facility. Infect Control Hosp Epidemiol 2011 Sep; 32(9): 837–44.
Winston CA, Navin TR, Becerra JE, LoBue PA. No rebound in tuberculosis in the United States in 2010. [Letter to the editor.] IJTLD 2011 Sept; 15(9): 1272–1273.
Winston CA, Navin TR, Becerra JE, Chen MP, Armstrong LR, Jeffries C, Woodruff RSY, Wing J, Starks AM, Hales CM, Kammerer JS, Mac Kenzie WR, Mitruka K, Miner MC, Price S, Scavotto J, Cronin AM, Griffin P, LoBue PA and Castro KG. Unexpected decline in tuberculosis cases coincident with economic recession – United States, 2009. BMC Public Health 2011; 11:846; doi:10.1186/1471-2458-11-846.
Yasinskaya Y, Plikaytis B, Sizemore C, Sacks L. Advancing the development of diagnostic tests and biomarkers for tuberculosis. [Notes from the field.] Int J Tuberc Lung Dis 2011 July; 15(7): 985–987.
Contact Us:
- Centers for Disease Control and Prevention
Division of Tuberculosis Elimination (DTBE)
1600 Clifton Rd., NE
MS E10
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov
